ArticleActa neurochirurgica2026
Prospective analysis of salivary melatonin levels in patients with symptomatic pineal cysts.
Article in Acta neurochirurgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMelatonin (ML) is synthesized in the pineal gland and is subject to a circadian rhythm. It significantly influences the sleep-wake cycle. Patients with non-hydrocephalic symptomatic pineal cysts (PC) suffer from a variety of symptoms including cephalgias and sleep disorders. However, the underlying pathomechanism remains unclear. Among others, a disturbed ML secretion due to the cyst is being discussed. However, the data regarding ML levels in patients with symptomatic PC is still insufficient.
methodsAs part of a prospective study in non-hydrocephalic patients with symptomatic PC, we examined the preoperative ML level in the saliva in a half-hour rhythm between 08:30 p.m. and 01:00 a.m.. In addition, symptoms, in particular sleep quality and headache, were recorded over a week using a diary. We analyzed the relationship between symptoms and the ML levels including their time course during early night hours.
resultsA total of ten female patients were included. The average diameter of the PC was 11 mm. Patients were able to sleep through the night on an average of 2.5 out of 7 days (range 0 - 6 days), problems falling asleep occurred on an average of 3.6 out of 7 days (range 0 - 7 days). Headaches occurred on an average of 5.5 out of 7 days (range 2 - 7 days). The severity of the headaches ranged from 3 to 7 on the visual analog scale (VAS). Four patients (40%) reported nausea. There was no significant correlation between ML levels and the recorded symptoms. However, the ML values showed a lack of increase during the night. In six patients, ML levels were within the normal range at 8:30 p.m. (p = 0.001). After 10:00 p.m. only two patients (p < 0.0001), and after 00:30 a.m. all patients had pathologic ML levels (p < 0.0001). Of these patients, two had ML values above, and seven below the normal range.
conclusionsThe ML levels in patients with symptomatic PC show a deficient nocturnal increase, which may provide an explanation for the symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.